NEW YORK , Jan. 21, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global heart valve repair and replacement devices market size is estimated to grow by USD 3.73 billion from 2025-2029, according to Technavio.
The market is estimated to grow at a CAGR of 9.1% during the forecast period. Rising competition and innovations in the overall heart valve repair and replacement devices market is driving market growth, with a trend towards data-oriented technologies drive growth of market.
However, shortage of cardiologists poses a challenge. Key market players include Abbott Laboratories, Artivion Inc., BioStable Science and Engineering Inc.
, Boston Scientific Corp., Colibri Heart Valve LLC, Edwards Lifesciences Corp., JenaValve Technology Inc.
, LivaNova PLC, Medtronic Plc, Micro Interventional Devices Inc., Neovasc Inc., Valcare Medical, and Xeltis AG.
AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF Key Market Trends Fueling Growth The Heart Valve Repair and Replacement Devices market encompasses solutions for treating damaged heart valves due to congenital, acquired, age-related changes, infections, heart attacks, calcific degeneration, and other heart diseases. Heart valves, including mitral and aortic, can be affected by regurgitation, stenosis, and damage leading to heart failure, stroke, blood clots, and even death.
Treatment optio.